Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 12 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Lithographic apparatus and device manufacturing method
Method for transforming a single reactor line
Systems and methods for programming an RFID reader
Cosmetic composition based on a supramolecular polymer and a hyperbranched functional polymer
Defected ground plane inductor
Chitosan hydrogel derivatives as a coating agent with broad spectrum of antimicrobial activities
Liquid crystal shutter glasses
  Randomly Featured Patents
Method and apparatus for precooling the helium tank of a cryostat
Type font
Playground padded sloped walkway and an enclosing structure
Framework for high-performance hardware abstraction
Method for the automatic identification of the type of measuring head of a fiber optic measurement value acquisition and transmission device
Aerosol dispenser for fluid products comprising a piston pump assembly for generating compressed air
Programmable hyper-spectral infrared focal plane arrays
Extrusion for base of linear lighting apparatus
Fiber finishing methods
Seawater pressure-driven desalinization apparatus with gravity-driven brine return